WVE Q3 2021 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$36M+955.7% YoY

Gross Profit

$5M14.7% margin

Operating Income

-$8M-20.9% margin

Net Income

-$6M-17.1% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+1212.1%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$201M

Total Liabilities

$171M

Stockholders' Equity

$30M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$3M	+955.7%
Gross Profit	$5M	-$25M	+121.5%
Operating Income	-$8M	-$34M	+77.9%
Net Income	-$6M	-$33M	+81.2%